Found 615 matching trials
Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER)
NAThis is a multi-site, prospective, non-randomised trial assessing the imple...
Location
The Sutherland Hospital
Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I)
N/AThe aim of the study is estimating the predictive and preventative capabili...
Location
Dmitry Rogachev National Medical Research Centre of Pediatric Hematology, Oncology and Immunology
Montelukast - a Treatment Choice for COVID-19
N/AThe current study aimed to make a therapeutic comparison and effectiveness ...
Location
Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China
Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation
PHASE3Leronlimab (PRO 140) is a humanized IgG4,k monoclonal antibody (mAb) that r...
Location
Hospital Dr Jayme dos Santos Neves
Convalescent Plasma for Treatment of COVID-19
PHASE2Convalescent plasma has been shown to be safe and effective for treatment o...
Location
Department of Infectious Disease, Falu Hospital
Ozone Auto-hemotherapy for COVID-19 Pneumonia
PHASE3This is a multicenter, randomized, controlled, open-label clinical trial te...
Location
Hospital Universitari Dr Josep Trueta
Efficacy and Safety of Sirolimus in COVID-19 Infection
PHASE2This research is planned to illustrate the efficacy and safety of sirolimus...
Location
Faculty of Medicine, Alexandria university, Egypt
Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19
PHASE3This phase III trial compares low dose whole lung radiation therapy to best...
Location
Emory University Hospital/Winship Cancer Institute
Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia
PHASE2This single-center, prospective, open-label, comparator study, blind for ce...
A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia
PHASE2This is a Phase II, randomized, double-blind, placebo-controlled, multicent...
Location
University of Arkansas For Medical Sciences